Anavex Life Sciences Corp (AVXL)

[Doc328]

Nobody was pleased with the decision to sell stock in 2021

I was and posted about it in February 2021. Though my position is now very small, for Anavex's financial health, Missling should sell shares at every pop, whether its due to great AVXL news or even more so if, as back in Feb 2021, its due to exogenous news (SAVA) and AVXL is just along for the ride. If, as I believe, an actual P3 will be needed for approval, that will cost 80 million over 2-3 years. As staff has increased and studies continue, AVXL will need a lot more funds. Cash should never get below 75-100 million so better to dilute minimally at each pop. Raising funds is more difficult in the current environment and may worsen over the next 2 years. If cash ever fell below 50 million, AVXL would be in huge trouble trying to raise more funds.